Welcoming Daniel J. Wallace, MD to Lupus Therapeutics News and Stories The Lupus Research Alliance (LRA) affiliate Lupus Therapeutics is pleased to announce that Daniel J. Wallace, MD joins as...
Dr. Daniel Wallace Appointed to Lupus Therapeutics Board Press Release New York, NY, July 18, 2019 — Renowned Dr. Daniel Wallace joined the Lupus Research Alliance (LRA) affiliate Lupus Therapeutics Board of Directors. ...
Angelica Perez Finds a Simple Way to Make a Huge Difference – You Can Too! Story Participating in the LRA’s Lupus Landmark Study was a “no-brainer” says Angelica Perez, a 37-year-old woman living with lupus...
Lupus Therapeutics, Affiliate of Lupus Research Alliance, Developing a Study Focused on Lupus Patients and COVID-19 Press Release New York, NY, April 7, 2020 – Lupus Therapeutics, the clinical trial affiliate of the Lupus Research Alliance (LRA),...
Lupus Therapeutics, filial de Lupus Research Alliance, desarrolla un estudio que se enfoca en los pacientes con lupus y la COVID-19 News and Stories 7 de abril de 2020 Nueva York, NY, 7 de abril de 2020 – Lupus Therapeutics, la filial de ensayos...
ACR|ARHP News on Potential New Lupus Treatments News and Stories October 25, 2018 The Lupus Research Alliance was on the ground at the American College of Rheumatology 2018 meeting to...
Study Shows Kidney Transplant Improves Lupus Nephritis Survival News and Stories January 21, 2019 A study just published in Annals of Internal Medicine showed that kidney transplantation reduced deaths due to lupus...
Patients with Lupus Nephritis-Related Kidney Disease Are Living Longer News and Stories March 28, 2019 A new study published this March in Arthritis & Rheumatology found that deaths among patients with end-stage...
New Study Shows Active Epstein-Barr Virus Increases Chance for Lupus in At-Risk People News and Stories August 13, 2019 New research results showed that active Epstein-Barr virus increases the risk for lupus among relatives of people...
MARCH 26 STATEMENT: Lupus Research Alliance Puts Plaquenil (Hydroxychloroquine) Shortage into Perspective for Lupus Community Press Release March 26, 2020 The Lupus Research Alliance (LRA), the world’s leading research organization dedicated to lupus research, continues to watch...
DECLARACIÓN DEL 26 DE MARZO: La Alianza para la investigación de Lupus pone en perspectiva la escasez de Plaquenil (hidroxicloroquina) para la comunidad con lupus News and Stories 26 de marzo de 2020 La Alianza para la investigación de Lupus (LRA), la principal organización de investigación del mundo...